PT Diastika Biotekindo Tbk
PT Diastika Biotekindo Tbk engages in the sale of disposable or consumable medical goods and diagnostic equipment. The company offers various products for detecting, diagnosing, and monitoring human disease. It also offers life science products that are processed from biological products. PT Diastika Biotekindo was founded in 1989 and is headquartered in Jakarta Timur, Jakarta Raya, Indonesia. PT… Read more
Market Cap & Net Worth: PT Diastika Biotekindo Tbk (CHEK)
PT Diastika Biotekindo Tbk (JK:CHEK) has a market capitalization of $81.80 (Rp1.33 Million) as of March 18, 2026. Listed on the JK stock exchange, this Indonesia-based company holds position #50171 globally and #911 in its home market, demonstrating a 0.73% increase in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying PT Diastika Biotekindo Tbk's stock price Rp138.00 by its total outstanding shares 9643 (9.64K).
PT Diastika Biotekindo Tbk Market Cap History: 2025 to 2026
PT Diastika Biotekindo Tbk's market capitalization history from 2025 to 2026. Data shows growth from $96.61 to $81.80 (0.00% CAGR).
PT Diastika Biotekindo Tbk Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how PT Diastika Biotekindo Tbk's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.
Latest Price to Sales (P/S) Ratio
No P/S ratio data available
Latest Price to Earnings (P/E) Ratio
No P/E ratio data available
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| No financial ratio data available | |||||
Competitor Companies of CHEK by Market Capitalization
Companies near PT Diastika Biotekindo Tbk in the global market cap rankings as of March 18, 2026.
Key companies related to PT Diastika Biotekindo Tbk by market ranking:
- Abbott Laboratories (NYSE:ABT): Ranked #79 globally with a market cap of $190.05 Billion USD.
- Stryker Corporation (NYSE:SYK): Ranked #153 globally with a market cap of $121.18 Billion USD.
- Medtronic PLC (NYSE:MDT): Ranked #169 globally with a market cap of $112.92 Billion USD.
- Boston Scientific Corp (NYSE:BSX): Ranked #191 globally with a market cap of $103.18 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #79 | Abbott Laboratories | NYSE:ABT | $190.05 Billion | $109.95 |
| #153 | Stryker Corporation | NYSE:SYK | $121.18 Billion | $349.56 |
| #169 | Medtronic PLC | NYSE:MDT | $112.92 Billion | $88.24 |
| #191 | Boston Scientific Corp | NYSE:BSX | $103.18 Billion | $69.79 |
PT Diastika Biotekindo Tbk Historical Marketcap From 2025 to 2026
Between 2025 and today, PT Diastika Biotekindo Tbk's market cap moved from $96.61 to $ 81.80, with a yearly change of 0.00%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | Rp81.80 | -15.34% |
| 2025 | Rp96.61 | -- |
End of Day Market Cap According to Different Sources
On Mar 17th, 2026 the market cap of PT Diastika Biotekindo Tbk was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $81.80 USD |
| MoneyControl | $81.80 USD |
| MarketWatch | $81.80 USD |
| marketcap.company | $81.80 USD |
| Reuters | $81.80 USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.